<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82470">
  <stage>Registered</stage>
  <submitdate>12/12/2007</submitdate>
  <approvaldate>17/12/2007</approvaldate>
  <actrnumber>ACTRN12607000640404</actrnumber>
  <trial_identification>
    <studytitle>Prospective trial of selective ultrasound-guided obturator nerve blockade for total knee replacement.</studytitle>
    <scientifictitle>Prospective trial on efficacy of selective ultrasound-guided obturator nerve blockade for total knee replacement</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Patients undergoing unilateral total knee replacement.</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Selective ultrasound-guided obturator nerve blockade performed preoperatively (using ropivacaine 37.5-75mg), in addition to continuous femoral nerve blockade (ropivacaine 75-150mg) and spinal anaesthesia (isobaric bupivacaine 15-20mg). Postoperative analgesia provided by femoral nerve local anaesthetic infusion (ropivacaine 16-24mg/hr), and morphine patient-controlled analgesia device (morphine 1mg bolus at 5min lockout).</interventions>
    <comparator>Continuous femoral nerve blockade (ropivacaine 75-150mg bolus) and spinal anaesthesia only (isobaric bupivacaine 15-20mg). Postoperative analgesia provided by femoral nerve local anaesthetic infusion (ropivacaine 16-24mg/hr), and morphine patient-controlled analgesia device (morphine 1mg bolus at 5min lockout).</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cumulative morphine requirements.</outcome>
      <timepoint>6hrs, 12hrs  and 24hrs post-surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Block performance time</outcome>
      <timepoint>Measured during block placement, from time of needle insertion to time of needle removal.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Hip adductor strength</outcome>
      <timepoint>Measured at 6hrs post-surgery.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cutaneous sensory deficit in obturator nerve distribution.</outcome>
      <timepoint>Measured at 6hrs post-surgery.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Visual analogue pain scores.</outcome>
      <timepoint>6hrs, 12hrs, 24hrs post-surgery.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patient satisfaction.</outcome>
      <timepoint>Measured at 24hrs.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Complications.</outcome>
      <timepoint>Assessed at 10 days postoperatively.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Undergoing unilateral total knee replacement.
Communicative in English.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Without preexisting lower limb neurological deficits.
Without opioid tolerance.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Screening for eligibility.
Following consent, randomisation by sealed envelopes.</concealment>
    <sequence>Computer generated.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>1/02/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>3065</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Timothy Lee</primarysponsorname>
    <primarysponsoraddress>Department of Anaesthesia, St Vincent's Hospital</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Department of Anaesthesia</fundingname>
      <fundingaddress>Department of Anaesthesia,
St Vincent's Hospital,
Victoria Parade,
Fitzroy, Victoria 3065</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Michael Barrington</sponsorname>
      <sponsoraddress>Department of Anaesthesia, St Vincent's Hospital</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Prospective trial of selective ultrasound-guided obturator block to determine its efficacy in providing analgesia following total knee joint replacement.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee D</ethicname>
      <ethicaddress>Research and Grants Unit,
St Vincent's Hospital,
Victoria Parade,
Fitzroy, Victoria 3065</ethicaddress>
      <ethicapprovaldate />
      <hrec>070/07</hrec>
      <ethicsubmitdate>3/07/2007</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Timothy Lee</name>
      <address>Department of Anaesthesia,
St Vincent's Hospital,
Victoria Parade,
Fitzroy, Victoria 3065</address>
      <phone>92882211</phone>
      <fax />
      <email>timothy.lee@svhm.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Timothy Lee</name>
      <address>Department of Anaesthesia,
St Vincent's Hospital,
Victoria Parade,
Fitzroy, Victoria 3065</address>
      <phone>92882211</phone>
      <fax />
      <email>timothy.lee@svhm.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>